These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7985316)

  • 21. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
    Stanford JL; Feng Z; Hamilton AS; Gilliland FD; Stephenson RA; Eley JW; Albertsen PC; Harlan LC; Potosky AL
    JAMA; 2000 Jan; 283(3):354-60. PubMed ID: 10647798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based study of long-term functional outcomes after prostate cancer treatment.
    Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
    BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy.
    Wagner AA; Cheng PJ; Carneiro A; Dovirak O; Khosla A; Taylor KN; Crociani CM; McAnally KC; Percy A; Dewey LE; Sanda MG; Chang P
    J Urol; 2017 Jan; 197(1):109-114. PubMed ID: 27475967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
    Bruner DW; Hunt D; Michalski JM; Bosch WR; Galvin JM; Amin M; Xiao C; Bahary JP; Patel M; Chafe S; Rodrigues G; Lau H; Duclos M; Baikadi M; Deshmukh S; Sandler HM
    Cancer; 2015 Jul; 121(14):2422-30. PubMed ID: 25847819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy.
    Kao TC; Cruess DF; Garner D; Foley J; Seay T; Friedrichs P; Thrasher JB; Mooneyhan RD; McLeod DG; Moul JW
    J Urol; 2000 Mar; 163(3):858-64. PubMed ID: 10687992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.
    Hanlon AL; Watkins Bruner D; Peter R; Hanks GE
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):51-9. PubMed ID: 11163497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancer.
    Mazur DJ; Merz JF
    J Am Geriatr Soc; 1995 Sep; 43(9):979-84. PubMed ID: 7657938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications from treatment for prostate carcinoma among men in the Detroit area.
    Schwartz K; Bunner S; Bearer R; Severson RK
    Cancer; 2002 Jul; 95(1):82-9. PubMed ID: 12115320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer.
    Kedia S; Zippe CD; Agarwal A; Nelson DR; Lakin MM
    Urology; 1999 Aug; 54(2):308-12. PubMed ID: 10443730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
    Rodda S; Tyldesley S; Morris WJ; Keyes M; Halperin R; Pai H; McKenzie M; Duncan G; Morton G; Hamm J; Murray N
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):286-295. PubMed ID: 28433432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer.
    Lee WR; Schultheiss TE; Hanlon AL; Hanks GE
    Urology; 1996 Jul; 48(1):95-9. PubMed ID: 8693660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functional results and treatment of functional dysfunctions after radical prostatectomy].
    Salomon L; Droupy S; Yiou R; Soulié M
    Prog Urol; 2015 Nov; 25(15):1028-66. PubMed ID: 26519966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
    Madalinska JB; Essink-Bot ML; de Koning HJ; Kirkels WJ; van der Maas PJ; Schröder FH
    J Clin Oncol; 2001 Mar; 19(6):1619-28. PubMed ID: 11250990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Late effects following curative radiotherapy for prostate cancer].
    Fokdal LU; Høyer M
    Ugeskr Laeger; 2005 Sep; 167(37):3502-7. PubMed ID: 16159460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.
    Chen RC; Zhang Y; Chen MH; McMahon E; Loffredo M; McPherson CP; Nguyen AU; Nguyen PL; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1690-5. PubMed ID: 22502770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
    Fulmer BR; Bissonette EA; Petroni GR; Theodorescu D
    Cancer; 2001 Jun; 91(11):2046-55. PubMed ID: 11391584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
    Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
    BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
    Ficarra V; Borghesi M; Suardi N; De Naeyer G; Novara G; Schatteman P; De Groote R; Carpentier P; Mottrie A
    BJU Int; 2013 Aug; 112(3):338-45. PubMed ID: 23470027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.